Brief: Strides Pharma Science Receives Establishment Inspection Report From US FDA For Puducherry Facility

Strides Pharma Science

19/05/2023 04:20

May 19 (Reuters) - Strides Pharma Science Ltd  SRID.NS :
    * RECEIVED ESTABLISHMENT INSPECTION REPORT FROM US FDA FOR
ITS
PUDUCHERRY MANUFACTURING FACILITY
    * USFDA CLASSIFIED FACILITY FROM OFFICIAL ACTION INDICATED
TO
VOLUNTARY ACTION INDICATED
    * USFDA HAD CLASSIFIED STRIDES PUDUCHERRY FACILITY AS OAI IN
MAY
2019
    * POST RECLASSIFICATION, FILED ANDAS FROM FACILITY WILL NOW
START
RECEIVING APPROVALS

Source text for Eikon:  ID:nNSE9hwZhZ 
Further company coverage:  SRID.NS 

 ((reuters.briefs@thomsonreuters.com;))